rare blood coagulation disease

South Korea's SK Plasma on Wednesday announced the launch of full-scale production this month of the blood products albumin and immunoglobulin for S...

Asan Medical Center announced plans on Thursday to establish a 65-bed gastrointestinal specialized hospital in Dubai Healthcare City in Dubai, UAE, ...

South Korean genome editing developer ToolGen Inc. has teamed up with Lartbio Technology, a Seoul-based transgenic animal development company, to de...

Busan Equity Partners (BEP), a South Korean private equity firm, is partnering with Philippine mineral development company PGMPI to develop overseas...

An early-stage startup by young entrepreneurs who developed a digital diagnostic tool for brain disease and an AI-powered business optimization prog...

GC Biopharma Corp., a South Korean pharmaceutical company, announced on Thursday that it has received approval from the Indonesian Ministry of Healt...

South Korea's Samsung Bioepis has received approval in Europe to sell a biosimilar of Soliris, a drug for the treatment of adult and children patien...

South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...

The number of young workers in South Korea fell for a sixth straight month in April to its lowest point in more than two years, deepening concerns t...

South Korea's Daewoong Pharmaceutical announced on Friday that it has signed a technology export contract for the clinical development and commercia...

South Korean biopharmaceutical company Celltrion Healthcare Co. on Thursday said it ranked in the top 10 out of 400 companies last year on the Turki...

Kolmar BNH Co. has received approval from the US Food and Drug Administration (FDA) for a domestically developed health functional food ingredient.K...

South Korean drugmaker Daewoong Pharmaceutical Co. said on Tuesday that it has signed a cooperation agreement with Sygnature Discovery, a British ne...

South Korea's steelmaker POSCO and the government-run Korea Mine Rehabilitation and Mineral Resources Corp. (KOMIR) on Friday announced the first pi...

South Korea's pharmaceutical company HLB Therapeutics Co. announced on Thursday that it has started patient administration of "RGN-259," a treatment...

South Korean chemical company LG Chem Ltd. has announced the release of a new diabetes combination drug, Zemidapa Tab, set to launch on Apr. 8. Th...

Koo Kwang-mo, chairman of South Korea’s fourth-largest conglomerate LG, has been sued over the distribution of inherited wealth, including a s...

Medical IP, a South Korean medical AI company, has announced that its artificial intelligence (AI) medical image analysis software "TiSepX Lung Volu...

South Korea’s SK Plasma will build a blood products plant in Indonesia.Industry sources on Tuesday said the company recently received approval...

Samsung Bioepis Co., a South Korean biosimilar firm, announced on Sunday that it has recently launched a new biosimilar drug called SB11 for the tre...

South Korea's GC Biopharma Corp. announced on Tuesday that it had entered into an agreement to transfer assets with Catalyst Biosciences, a US-based...

South Korea's Daesang Wellife Corp. has inked a 2 billion won ($1.5 million) investment contract with local healthcare data science company RexSoft ...

South Korea's biohealth company HK inno.N said on Tuesday that its gastroesophageal reflux disease (GERD) treatment K-CAB (active ingredient: tegopr...

South Korean pharmaceuticals firm Hanall Biopharma Co. is investing in Interon Laboratories, a US biotech firm that finds and develops treatments fo...

South Korean medical devices maker, Humasis Co., is participating in the MEDLAB Middle East 2023 event taking place at the Dubai World Trade Center ...

South Korea's telecom operator KT Corp. said on Wednesday that it has signed a memorandum of understanding (MOU) with Mongolia's Monnis Group for co...

South Korea's biohealth company HK inno.N said on Wednesday that it has signed an agreement with Spanish pharmaceutical company mAbxience SA to intr...

Celltrion Inc. announced on Monday it applied to the European Medicines Agency (EMA) for approval of a 20 mg/0.2 mL formulation of Yuflyma, a biosim...

South Korea's biomedicine firm S.Biomedics said on Friday that it has won approval from the Ministry of Food and Drug Safety for phase 1 and 2a clin...

South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...